Guest editorial: Cerebrovascular injury in stroke

Neurological Research

Volumn 28, Issue 1, 2006, Pages 3-10

  Ding, Yuchuan ^a   Clark, Justin C ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR; CELL ADHESION MOLECULE; CYTOKINE;

CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; EDITORIAL; HUMAN; LIPID PEROXIDATION; MORBIDITY; MORTALITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROKE; ANIMAL; BRAIN INFARCTION; CELL DEATH; ENDOTHELIUM; INFLAMMATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; REPERFUSION;

ANIMALS; CELL ADHESION MOLECULES; CELL DEATH; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; CYTOKINES; ENDOTHELIUM; HUMANS; INFLAMMATION; INTEGRINS; LIPID PEROXIDATION; MATRIX METALLOPROTEINASES; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; REPERFUSION; SIGNAL TRANSDUCTION;

EID: 32044466942     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X91799     Document Type: Editorial

References (132)

1. Overgaard K. Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev 1994; 6: 257-286
2. Samama MM, Desnoyers PC, et al. Acute ischemic stroke and heparin treatments. Thromb Haemos 1997; 78: 173-179
3. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury Arch Neurol 1990; 47: 1245-1254
4. Zivin JA. Factors determining the therapeutic window for stroke. Neurology 1998; 50: 599-603
5. Ginsberg MD. Local metabolic responses to cerebral ischemia. Cerebrovasc Brain Metab Rev 1990; 2: 58-93
6. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77: 169-184
7. Siesjo BK: Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 1992; 77: 337-354
8. Aronowski J, Strong R, Grotta JC. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 1997; 17: 1048-1056
9. Clark RK, Lee EV, White RF, et al. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 1994; 35: 387-392
10. Kiessling M, Hossmann KA. Focal cerebral ischemia: Molecular mechanisms and new therapeutic strategies. Brain Pathol 1994; 4: 21-22
11. Bulkley GB. Pathophysiology of free radical-mediated reperfusion injury, J Vasc Surg 1987; 5: 512-517
12. Korthuis RJ, Granger DN, Townsley MI, et al. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 1985; 57: 599-609
13. Jean WC, Spellman SR, Nussbaum ES, et al. Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon. Neurosurgery 1998; 43: 1382-1396
14. DeGraba TJ. The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy. Neurology 1998; 51: S62-S68
15. Becker KJ. Inflammation and acute stroke. Curr Opin in Neurol 1998; 11: 45-49
16. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19: 819-834
17. del Zoppo GJ, Becker KJ, Hallenbeck JM. Inflammation after stroke: Is it harmful? Arch Neurol 2001; 58: 669-672
18. Chopp M, Zhang ZG. Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke. Curr Opin Neurol 1996; 9: 68-72
19. Ritter LS, Orozco JA, Coull BM, et al. Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke 2000; 31: 1153-1161
20. Pozzilli C, Lenzi GL, Argentino C, et al. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke 1985; 16: 251-255
21. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367-1379
22. Arvin B, Neville LF, Barone FC, et al. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996; 20: 445-452
23. Clark WM, Zivin JA. Antileukocyte adhesion therapy: Preclinical trials and combination therapy. Neurology 1997; 49: S32-S38
24. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998; 56: 149-171
25. Garcia JH, Pantoni L. Cellular inflammation in experimental ischemic stroke. In: Miller LP, ed. Stroke Therapy. Basic, Preclinical, and Clinical Directions. San Diego, CA: Metabasis Therapeutics, 1999: pp. 271-297
26. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 1999; 22: 391-397
27. Stanimirovic D, Satoh K. Inflammatory mediators of cerebral endothelium: A role in ischemic brain inflammation. Brain Pathol 2000; 10: 113-126
28. Hallenbeck JM, Dutka AJ, Tanishima T, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986; 17: 246-253
29. del Zoppo GJ, Schmid-Schonbein GW, Mori E, et al. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 22: 1276-1283
30. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4: 399-415
31. Jander S, Kraemer M, Schroeter M, et al. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 1995; 15: 42-51
32. Okada Y, Copeland BR, Mori E, et al. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994; 25: 202-211
33. Saito K, Suyama K, Nishida K, et al. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 1996; 206: 149-152
34. Uno H, Matsuyama T, Akita H, et al. Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 1997; 17: 491-499
35. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A 1997; 94: 2007-2012
36. Yoshimoto T, Houkin K, Tada M, et al. Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model. Acta Neuropathol 1997; 93: 154-158
37. Petty MA, Wettstein JG. Elements of cerebral microvascular ischaemia. Brain Res Brain Res Rev 2001; 36: 23-34
38. Dietrich JB. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J Neuroimmunol 2002; 128: 58-68
39. Carroll JE, Hess DC, Howard EF, et al. Is nuclear factor-kappaB a good treatment target in brain ischemia/reperfusion injury? Neuroreport 2000; 11: R1-R4
40. Stephenson D, Yin T, Smalstig EB, et al. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 2000; 20: 592-603
41. Schneider A, Martin V, Weih F, et al. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999; 5: 554-559
42. Berti R, Williams AJ, Moffett JR, et al. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab 2002; 22: 1068-1079
43. Chandrasekar B, Streitman JE, Colston JT, et al. Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim Biophys Acta 1998; 1406: 91-106
44. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270: 933-943
45. Read MA, Whitley MZ, Williams AJ, et al. NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-512
46. Howard EF, Chen Q, Cheng C, et al. NF-kappa B is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci Lett 1998; 248: 199-203
47. Rahman A, Anwar KN, True AL, et al. Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol 1999; 162: 5466-5476
48. Ginis I, Hallenbeck JM, Liu J, et al. Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Mol Med 2000; 6: 1028-1041
49. Hess DC, Howard E, Cheng C, et al. Hypertonic mannitol loading of NF-kappaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1. Stroke 2000; 31: 1179-1186
50. Aspey BS, Jessimer C, Pereira S, et al. Do leukocytes have a role in the cerebral no-reflow phenomenon? J Neurol Neurosurg Psychiatry 1989; 52: 526-528
51. Nishigaya K, Yoshida Y, Sasuga M, et al. Effect of recirculation on exacerbation of ischemic vascular lesions in rat brain. Stroke 1991; 22: 635-642
52. Ames A, Wright RL, Kowada M, et al. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1968; 52: 437-453
53. Mori E, del Zoppo GJ, Chambers JD, et al. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992; 23: 712-718
54. Dietrich WD, Busto R, Yoshida S, et al. Histopathological and hemodynamic consequences of complete versus incomplete ischemia in the rat. J Cereb Blood Flow Metab 1987; 7: 300-308
55. Choudhri TF, Hoh BL, Zerwes HG, et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 1998; 102: 1301-1310
56. Dietrich WD, Busto R, Ginsberg MD. Cerebral endothelial microvilli: Formation following global forebrain ischemia. J Neuropathol Exp Neurol 1984; 43: 72-83
57. Wood JH, Kee DJ. Hemorheology of the cerebral circulation in stroke. Stroke 1985; 16: 765-772
58. Garcia JH, Liu KF, Yoshida Y, et al. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994; 144: 188-199
59. Hossmann KA. Reperfusion of the brain after global ischemia: Hemodynamic disturbances. Shock 1997; 8: 95-101
60. Chiang J, Kowada M, Ames A, et al. Cerebral ischemia. Vascular changes. Am J Pathol 1968; 52: 455-476
61. Dougherty JH, Levy DE, Weksler BB. Experimental cerebral ischemia produces platelet aggregation. Neurology 1977; 27: 382
62. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Circulation 1994; 89: 1469-1480
63. Okada Y, Copeland BR, Fitridge R, et al. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 1994; 25: 1847-1853
64. Siebler M, Nachtmann A, Sitzer M, et al. Anticoagulation monitoring and cerebral microemboli detection. Lancet 1994; 344: 555
65. Heye N, Cervos N. Microthromboemboli in acute infarcts: Analysis of 40 autopsy cases. Stroke 1996; 27: 431-434
66. Zhang ZG, Chopp M, Goussev A, et al. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. J Neurosci 1999; 19: 10898-10907
67. Dawson DA, Ruetzler CA, Hallenbeck JM. Temporal impairment of microcirculatory perfusion following focal cerebral ischemia in the spontaneously hypertensive rat. Brain Res 1997; 749: 200-208
68. Zhang Z, Davies K, Prostak J, et al. Quantitation of microvascular plasma perfusion and neuronal microtubule-associated protein in ischemic mouse brain by laser-scanning confocal microscopy. J Cereb Blood Flow Metab 1999; 19: 68-78
69. Botchkina GI, Meistrell ME, Botchkina IL, et al. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 1997; 3: 765-781
70. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-1488
71. Buttini M, Appel K, Sauter A, et al. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neurosci 1996; 71: 1-16
72. Sairanen TR, Lindsberg PJ, Brenner M, et al. Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J Neurol Sci 2001; 186: 87-99
73. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002; 8: 1363-1368
74. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 1999; 10: 119-130
75. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11: 372-377
76. Gary DS, Bruce K, Kindy MS, et al. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 1998; 18: 1283-1287
77. Shen Y, Li R, Shiosaki K. Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in human neuronal cell line. J Biol Chem 1997; 272: 3550-3553
78. Yang L, Lindholm K, Konishi Y, et al. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J Neurosci 2002; 22: 3025-3032
79. Nadeau S, Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neurosci 1999; 93: 1449-1464
80. Willuweit A, Sass G, Schoneberg A, et al. Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells. J Immunol 2001; 167: 3944-3952
81. Leeuwenberg JF, van T, Jeunhomme TM, et al. Evidence for exclusive role in signalling of tumour necrosis factor p55 receptor and a potentiating function of p75 receptor on human endothelial cells. Cytokine 1995; 7: 457-462
82. Ferrero E, Zocchi MR, Magni E, et al. Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability. Am J Physiol Cell Physiol 2001; 281: C1173-C1179
83. Akassoglou K, Douni E, Bauer J, et al. Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice. Proc Natl Acad Sci U S A 2003; 100: 709-714
84. Facchinetti F, Dawson VL, Dawson TM. Free radicals as mediators of neuronal injury. Cell Mol Neurobiol 1998; 18: 667-682
85. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990; 21: 1086-1090
86. Phillis JW, Regan MH. GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex. Neuroreport 1995; 6: 2010-2012
87. Watson BD. Usual and unusual methods for detection of lipid peroxides as indicators of tissue injury in cerebral ischemia: What is appropriate and useful? Cell Mol Neurobiol 1998; 18: 581-598
88. Hall ED. Free radicals in stroke. In: Miller LP, ed. Stroke Therapy. Basic, Preclinical, and Clinical Directions. San Diego, CA: Metabasis Therapeutics, 1999: pp. 245-270
89. White BC, Sullivan JM, DeGracia DJ, et al. Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. J Neurol Sci 2000; 179: 1-33
90. Romanic AM, White RF, Arleth AJ, et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29: 1020-1030
91. Gasche Y, Fujimura M, Morita F, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999; 19: 1020-1028
92. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29: 2189-2195
93. Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999; 19: 624-633
94. Planas AM, Sole S, Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 2001; 8: 834-846
95. Planas AM, Sole S, Justicia C, et al. Estimation of gelatinase content in rat brain: Effect of focal ischemia. Biochem Biophys Res Commun 2000; 278: 803-807
96. Wagner S, Nagel S, Kluge B, et al. Topographically graded postischemic presence of metalloproteinases is inhibited by hypothermia. Brain Res 2003; 984: 63-75
97. Pfefferkorn T, Rosenberg GA. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 2003; 34: 2025-2030
98. Clark AW, Krekoski CA, Bou SS, et al. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 1997; 238: 53-56
99. Fujimura M, Gasche Y, Morita F, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92-100
100. Yong VW, Power C, Forsyth P, et al. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2: 502-511
101. Lo EH, Wang X, Cuzner ML. Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 2002; 69: 1-9
102. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21: 7724-7732
103. Asahi M, Asahi K, Jung JC, et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 1681-1689
104. Wang X, Jung J, Asahi M, et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 2000; 20: 7037-7042
105. Leib SL, Clements JM, Lindberg RL, et al. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 2001; 124: 1734-1742
106. Harkness KA, Adamson P, Sussman JD, et al. Dexamethasone regulation of matrix metal loproteinase expression in CNS vascular endothelium. Brain 2000; 123 (4): 698-709
107. Dans MJ, Giancotti FG. Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins, edn 2. Oxford: Sambrook & Tooze Publication at Osford University Press, 1999.
108. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001; 305: 285-298
109. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25
110. del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 2003; 23: 879-894
111. Brett J, Gerlach H, Nawroth P, et al. Tumor necrosis factor/ cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169: 1977-1991
112. Curtis TM, McKeown L, Vincent PA, et al. Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-alpha 5 beta 1, or TNF-alpha exposure. Am J Physiol 1995; 269: L248-L260
113. Rotundo RF, Curtis TM, Shah MD, et al. TNF-alpha disruption of lung endothelial integrity: Reduced integrin mediated adhesion to fibronectin. Am J Physiol Lung Cell Mol Physiol 2002; 282: L316-L329
114. Wheatley EM, Vincent PA, McKeown L, et al. Effect of fibronectin on permeability of normal and TNF-treated lung endothelial cell monolayers. Am J Physiol 1993; 264: R90-R96
115. Tawil N, Wilson P, Carbonetto S. Integrins in point contacts mediate cell spreading: Factors that regulate integrin accumulation in point contacts vs. focal contacts. J Cell Biol 1993; 120: 261-271
116. Tawil NJ, Wilson P, Carbonetto S. Expression and distribution of functional integrins in rat CNS glia. J Neurosci Res 1994; 39: 436-447
117. Tagaya M, Haring HP, Stuiver I, et al. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 2001; 21: 835-846
118. Wagner S, Tagaya M, Koziol JA, et al. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion. Stroke 1997; 28: 858-865
119. Hamann GF, Liebetrau M, Martens H, et al. Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 2002; 22: 526-533
120. Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol 2003; 28: 229-244
121. Burgess ML, Terracio L, Hirozane T, et al. Differential integrin expression by cardiac fibroblasts from hypertensive and exercise-trained rat hearts. Cardiovasc Pathol 2002; 11: 78-87
122. Jordan J, Beneke R, Hutler M, et al. Moderate exercise leads to decreased expression of beta1 and beta2 integrins on leucocytes. Eur J Appl Physiol Occup Physiol 1997; 76: 192-194
123. Previtali SC, Archelos JJ, Hartung HP. Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis. A central role for TNF-alpha. Am J Pathol 1997; 151: 1425-1435
124. Gao B, Saba TM, Tsan MF. Role of alpha(v)beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am J Physiol Cell Physiol 2002; 283: C1196-C1205
125. Milner R, Campbell IL. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol 2003; 170: 3850-3858
126. Kettritz R, Choi M, Rolle S, et al. Integrins and cytokines activate nuclear transcription factor-kappaB in human neutrophils. J Biol Chem 2004; 279: 2657-2665
127. Gao B, Curtis TM, Blumenstock FA, et al. Increased recycling of (alpha)5(beta)1 integrins by lung endothelial cells in response to tumor necrosis factor. J Cell Sci 2000; 113 Pt 2: 247-257
128. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 2591-2599
129. Defilippi P, Silengo L, Tarone G. Alpha 6.beta 1 integrin (laminin receptor) is down-regulated by tumor necrosis factor alpha and interleukin-1 beta in human endothelial cells. J Biol Chem 1992; 267: 18303-18307
130. Yamasaki Y, Suzuki T, Yamaya H, et al. Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci Lett 1992; 142: 45-47
131. Zhang LF, Yang J, Hong Z, et al. Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke 2003; 34: 2091-2096
132. Cheng XM. (2000) Epidemiology of cerebrovascular diseases. In: Li SC, Cheng XM, Wang WJ, et al., eds. Epidemiology of Diseases in Nerve System. (Beijing: People's Medical Publishing House, 2000: pp. 72-87